Nogo-A reduces ceramide <i>de novo</i> biosynthesis to protect from heart failure

Abstract

Mechanistically, Nogo-A refrains ceramides from accrual, therefore preserves the 'beneficial' autophagy, mitochondrial function, and metabolic gene expression, limiting the progression to HF under sustained stress.